Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04271254 · ClinicalTrials.gov registry record · NA
PET/MR Characterization of Renal Cell Carcinomas
A NA study, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT04271254 is a NA study that was terminated before completion, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 5 participants.
The verdict
NCT04271254, a NA study, was terminated before completion, sponsored by UNC Lineberger Comprehensive Cancer Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
Purpose: To evaluate the utility of simultaneous positron emission tomography (PET) and magnetic resonance imaging (MRI) in characterizing the molecular subtypes of clear cell renal cell carcinomas (ccRCC) to potentially inform prognosis and treatment decisions. Participants: Seventeen subjects diagnosed with clear-cell renal cell carcinoma (ccRCC) will be imaged in a single session on PET-MRI. Procedures (methods): The investigators will image 17 ccRCC subjects on simultaneous PET-MRI and quantify the metabolically-active fraction of the tumor from images. Ten core samples will be taken from each tumor post-surgery and classified as ccA or ccB subtype using transcriptome analysis. The imaging-based measures will be correlated with the fraction of tumor cores classified as ccB.
Interventions
- DIAGNOSTIC_TEST PET/MR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2020-10-01 |
| Est. Completion | 2023-06-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04271254
The ClinicalTrials.gov registry entry for NCT04271254 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UNC Lineberger Comprehensive Cancer Center, which has 366 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PET/MR is the first listed.
NCT04271254 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04271254 about?
NCT04271254 is a clinical study titled "PET/MR Characterization of Renal Cell Carcinomas". Purpose: To evaluate the utility of simultaneous positron emission tomography (PET) and magnetic resonance imaging (MRI) in characterizing the molecular subtypes of clear cell renal cell carcinomas (ccRCC) to potentially inform prognosis and treatment decisions. Participants: Seventeen subjects dia...
What is the current status of trial NCT04271254?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2020-10-01. Estimated completion is 2023-06-14.
What interventions are being tested in trial NCT04271254?
The interventions under investigation include: PET/MR (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04271254?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.